Vaxcyte's market cap is currently $5.64B. The company's EPS TTM is $-1.56; its P/E ratio is -8.88; Vaxcyte is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $-1.50. See an overview of income statement, balance sheet, and cash flow financials.
